Program

Dr. Gerald Batist M.D. Director of the McGill Centre for Translational Research and Associate Director of the Axe Experimental Therapies RRCancer

Chair: Shirin Enger PhD, Director of Medical Physics Unit, McGill University Keynote Lecture: "The Alberta linac-MR to treat all cancer tumours" Dr. Gino Fallone PhD, Director of the Division of Medical Physics, Department of Oncology at the University of Alberta. Director of Medical Physics, Cross Cancer Institute (Cancer Clinic). Chairman and co-founder, MagnetTx Oncology Solutions, Ltd. Talk 1 : "Transrectal 3D ultrasound for brachytherapy and colorectal cancer imaging" Dr. Aaron Fenster PhD, Professor at the Department of Biomedical Engineering and Oncology, University of Western Ontario Talk 2 : "Innovation and Opportunities in Theranostic Radiopharmaceuticals" Dr. Karin Stephenson PhD, Director of Nuclear Research and Education Support of Nuclear Operations & Facilities, McMaster University. Talk 3 : "Development of cost-efficient brain imaging tools for targeted treatment across all settings" Dr. Udunna Anazodo PhD, Assistant Professor in at the Department of Neurology and Neurosurgery, McGill University

Chair: Dr. Gerald Batist M.D. Director of the McGill Centre for Translational Research and Associate Director of the Axe Experimental Therapies RRCancer Talk 1: "Value based care transformation at CIUSSS Centre-Ouest" Mrs. Erin Cook Director of Quality, Transformation, Evaluation, Value, Ethics, and Virtual Care at CIUSSS West-Central Talk 2: "The Patient Values Project: Understanding Patient Preferences for Cancer Treatments to Inform a Framework for Incorporating Patient Values Into Health Technology Assessment" Mr. Barry D. Stein President and Chief Executive Officer at Colorectal Cancer Canada Talk 3: "Incorporating AI & Operations Research to Optimize & Automate the Scheduling of Cancer Care Trajectories" Dr. André Diamant Ph.D. Founder & Chief Executive Officer of Gray Oncology Solutions

Chair: Dr. Miriam Santos Dutra Ph.D., Chief Operating Officer of McGill Centre of Translational Research in Cancer at the Jewish General Hospital Talk: "ML/AI-enabled vaccine design: From bench to the start-up journey" Dr. Ariane Gomes Ph.D., Scientist Director and CEO of BaseImmune

Chair: Dr. Mark Basik MD, Professor, Departments of Surgery and Oncology, McGill University Keynote lecture: "My path from academic discovery research to industrial drug development" Dr. Spyro Mousses PhD, Co-Founder and Chief Executive Officer of Systems Oncology Talk 1: "Juggling the academic duties, the scientific challenges, and the roller coaster of the private sector: Progress with Kanyr Pharma Inc." Dr. Michel Tremblay PhD, Distinguished James McGill Professor, Department of Biochemistry at McGill University and Chief Scientific Officer at Kanyr Pharma Inc. Talk 2: "Nanofilament immunotherapy for the treatment of solid tumors" Dr. François Millau PhD. Co-founder and Chief Executive Officer of TATUM Bioscience

Ms. Katie Bozek PhD Candidate, Experimental Medicine, McGill University “Deciphering the Role of FGD1 in Melanoma Progression” , presented by Guy Namir “Detection of Circulating Tumor DNA After Neoadjuvant Chemotherapy Predicts Distant Relapse-Free Survival, Local Recurrence, and Distant Recurrence in Triple Negative Breast Cancer: Findings from the TRICIA Study”, presented by Talia Roseshter “From Radiotherapy to Immunotherapy: Potential of High Dose Rate Endorectal Brachytherapy for Improved Outcomes in Rectal Cancer”, presented by Emma Starr

Chair Dr. Adriana Aguilar PhD. Directrice scientifique du Laboratoire de génomique du cancer et de recherche translationnelle, Université McGill Talk 1: "Single-EV Fingerprinting: A New Paradigm in Liquid Biopsy for Cancer" Dr. Sara Mahshid PhD. Professor at the Department of Bioengineering, McGill University Talk 2: "Plasma ctDNA profiling in clinical trials" Dr. Nathalie Johnson MD. Associate Professor at the Department of Oncology, McGill University Talk 3: Implementation of ctDNA in the clinic: Optilab in the context of Quebec Network for molecular profiling" Dr. Alan Spatz MD. PhD. Full Professor at the Department of Pathology, McGill University

Chair Dr. Michael Witcher PhD. Assistant Professor at the Department of Oncology, McGill University Talk 1: "Translating discoveries into therapeutic solutions in academia" Dr. Michel Bouvier PhD. Professor of Biochemistry and Molecular Medicine and principal investigator at IRIC, Université de Montréal Talk 2: "Stem Cell Engineering for Cancer Immunotherapy, Experience in the First Steps of Collaboration with a New Company" Dr. Elie Haddad MD. PhD. Full Professor, Department of Pediatrics, Department of Microbiology, Immunology and Infectiology, Faculty of Medicine at University of Montreal Talk 3: Optimizing precision therapies for metastatic prostate cancer Dr. April Rose MD. PhD. Assistant Professor at the Department of Oncology, McGill University

Dr. Mark Basik MD, Professor, Oncology Department, McGill

17:30-18:15 Poster Evaluation Period 19:00 Best Presentations Award Ceremony